ANTHEM

NSE#317 by turnover

Anthem Biosciences Limited

₹873.60-12.00 (-1.36%)Close, 25 Sept 2026

Key statistics

Open: ₹888.00
Day range: 869.40 – 890.85
52-week range: 579.15 – 977.55
From 52w high: -10.6%
Volume: 3.73L
Turnover: ₹32.6Cr
Delivery: 49.4%
Rel volume: 0.38×
RSI (14): 41.5
ATR (14): 28.87
SMA 50: 872.17
SMA 200: 745.37

Performance

1 day: -1.36%
1 week: -5.91%
1 month: -5.36%
3 months: +12.72%
6 months: +39.01%
1 year: +1.93%

Delivery percentage

Latest: 49.4%
20-day avg: 54.4%
1-year avg: 54.4%
Percentile: 39th
Range: 18.0–89.1%

Over the last 20 sessions ANTHEM settled 54.4% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 54.4%. The latest session ranks higher than 39% of the 294 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

Fundamentals

Market cap: ₹49,230 Cr
P/E (TTM): 85.48
EPS (TTM): ₹10.22
Shares outstanding: 56.34Cr
Listed: 21 Jul 2025

Classification

Macro sector: Healthcare
Sector: Healthcare
Industry: Pharmaceuticals & Biotechnology
Basic industry: Biotechnology

NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.

Growthlatest filed quarter Q1 FY27

Revenue YoY: -22.58%
Profit YoY: -11.67%
Revenue QoQ: -31.55%
Profit QoQ: -36.79%
Interest cost YoY: —

Compound growth

Not enough filed history for a compound growth rate yet.

Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.

About

ISIN: INE0CZ201020
Series: EQ
History from: 21 Jul 2025
Sessions: 294

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.